XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Net Income Per Common Share
3 Months Ended
Apr. 04, 2021
Net Income per Common Share
N. NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per common share:
 
    
For the Three Months Ended
 
    
April 4,

2021
    
March

29, 2020
 
    
(in thousands, except per share amounts)
 
Net income for basic and diluted net income per share
   $ 205,512      $ 176,191  
    
 
 
    
 
 
 
Weighted average common shares-basic
     166,491        166,589  
Effect of dilutive potential common shares:
                 
Incremental shares from assumed conversion of convertible notes (1)
     10,310        7,333  
Convertible note hedge warrant shares (2)
     9,429        5,492  
Restricted stock units
     1,395        1,163  
Stock options
     108        134  
Employee stock purchase plan
     7        25  
    
 
 
    
 
 
 
Dilutive potential common shares
     21,249        14,147  
    
 
 
    
 
 
 
Weighted average common shares-diluted
     187,740        180,736  
    
 
 
    
 
 
 
Net income per common share-basic
   $ 1.23      $ 1.06  
    
 
 
    
 
 
 
Net income per common share-diluted
   $ 1.09      $ 0.97  
    
 
 
    
 
 
 
 
(1)
Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price of $31.55, multiplied by 13.8 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.
(2)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $39.59, multiplied by 13.8 million shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
The computation of diluted net income per common share for the three months ended March 29, 2020 excludes the effect of the potential vesting of 0.3 million restricted stock units because the effect would have been anti-dilutive.